Organogenesis to unveil 2025 financial results on February 26, 2026

Organogenesis Holdings Inc. (ORGO) will release its fourth quarter and full-year 2025 finance results on February 26, 2026. The company has scheduled a conference call later that day to review the figures and share a corporate update with investors.

The finance announcement will take place after the market closes on February 26, 2026. Investors and analysts can then join a live conference call at 5:00 p.m. Eastern Time to discuss the performance and future plans.

Those interested in listening can access the webcast through the company's investor relations page at investors.organogenesis.com. The latest available share price for ORGO stands at around $3.40, though the stock has shown significant volatility over the past year in the stock market.

No specific data has been released comparing 2025 stock market performance to 2024. The company has not provided detailed projections or historical comparisons for that period in recent reports.

The upcoming call will offer insights into Organogenesis' finance health and strategic direction. Shareholders and market watchers can tune in via the company's website for the latest updates. The event follows a year of fluctuating stock prices, with the most recent trading sessions placing shares near $3.40 in the stock market.